Synthesis, radiolabeling, and investigation of bombesin-modified gadolinium nanoparticles as a potential SPECT/MRI agent for prostate cancer
Crossref DOI link: https://doi.org/10.1007/s10967-023-08965-7
Published Online: 2023-06-03
Published Print: 2023-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Akkaya, T. S.
Tutun, E.
Yasakçı, V.
Unak, P. http://orcid.org/0000-0002-5464-2987
Text and Data Mining valid from 2023-06-03
Version of Record valid from 2023-06-03
Article History
Received: 26 January 2023
Accepted: 17 May 2023
First Online: 3 June 2023
Declarations
:
: The authors declare no conflict of interest.